LEoPARD has been awarded an internal grant at maximum value — a full request of $2,000 — by the Vermont Biomedical Research Network (VBRN). Funds received from the grant application — entitled “Quantitative structure-activity relationship (QSAR) study of commercially-available capsaicin, capsaicinoids, capsinoids, and their biosynthetic intermediates: enzymatic and cellular approaches” — is added to a previous … Continue reading LEoPARD awarded internal grant from Vermont Biomedical Research Network
Laboratory for Evaluation of Pharmacological Agents in Remediation of Disease (LEoPARD) 